查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087725

治療床市場：2026-2032年全球市場預測（按產品類型、技術類型、治療類型、使用環境和最終用戶分類）

Therapeutic Bed Market by Product Type, Technology Type, Therapy Type, Usage Setting, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，治療床市場將成長至 69 億美元，複合年成長率為 5.29%。

主要市場統計數據
基準年 2025 48.1億美元
預計年份：2026年 50.5億美元
預測年份 2032 69億美元
複合年成長率 (%) 5.29%

治療床市場簡介

隨著醫療機構、長期照護機構、居家醫療機構和復健中心將預防壓瘡、提高病患活動能力、控制感染和提升營運效率列為優先事項，治療床市場正在不斷擴大。治療床包括低壓床、氣墊床、交替壓縮床墊、肥胖症專用床、重症監護床以及智慧醫院床，這些床的設計旨在重新分配壓力、改善體位、支持創傷護理並減輕看護者的負擔。

治療床產業的變革

隨著醫療模式從被動式患者護理轉向數據驅動的預防性護理，治療床領域正在經歷一場變革。醫院正在規範使用壓力分散床墊和先進的姿勢擺放系統，以降低醫院獲得性壓瘡的發生率。據美國醫療保健研究與品質署 (AHRQ) 稱，醫院獲得性壓瘡會導致嚴重的併發症，延長住院時間，並造成美國每年數十億美元的醫療支出。因此，治療床不再僅被視為資本投資，而是被視為能夠提升醫療品質的可衡量投資。

人工智慧（AI）的累積影響

人工智慧 (AI) 正在對治療床的設計、使用和服務提供等各個方面產生累積影響。 AI 驅動的床可以持續監測患者的活動、跌倒風險、濕度、體重變化和姿勢變換模式。將這些功能整合到臨床工作流程中，可以讓看護者優先考慮體位變換，識別跌倒風險，並對有壓瘡或呼吸系統併發症風險的患者進行早期介入。

全球治療床市場關鍵區域洞察

在亞太地區，醫院基礎設施的擴建、日本、中國和韓國人口老化以及印度和整個東南亞地區慢性病盛行率的上升，都在推動對治療床的需求。公立和私立醫院的投資也催生了對智慧病床、重症監護病床以及專為高患者量醫療環境量身定做的、經濟實惠的防壓瘡床墊的需求。

針對特定族群對治療床位需求的關鍵見解

在東南亞國協，由於醫院建設、都市化和醫療保健成本的不斷成長，對價格適中的治療床和壓瘡預防床墊的需求日益增加。該地區的採購通常需要在成本考量與產品耐用、易於維護以及適用於患者人數眾多和基礎設施各異的環境之間取得平衡。

來自治療床市場主要國家的洞察

由於美國醫療成本高昂、醫院網路大規模、對專業護理的需求旺盛、對肥胖患者照護的要求較高，以及高度重視壓瘡預防，因此美國是治療床市場最具影響力的國家。在加拿大，符合公共醫療採購和省級護理標準的、經臨床驗證且經久耐用的系統更受青睞。同時，墨西哥則受益於私立醫院的擴張、跨國醫療以及急診設施的現代化。

為行業領導者提供的實用建議

產業領導者應優先考慮具有臨床差異化優勢的治療床，這些治療床能夠顯著降低壓瘡風險、減輕看護者負擔、減少跌倒事故和運作。收集證據至關重要。製造商應投資於真實世界研究、衛生經濟學模型和基於結果的案例研究，以便採購團隊能夠透過降低總護理成本來證明引進高級產品的合理性。

調查方法

本執行摘要基於系統性的二手研究方法，利用公開且機構認可的資訊來源，包括衛生組織、人口統計資料庫、醫院品質文獻、醫療設備法規結構和醫療基礎設施研究途徑。主要參考文獻包括世界衛生組織 (WHO)、聯合國、世界銀行、醫療保健研究與品質署 (AHRQ) 和各國衛生部門等機構的數據和指南。

結論

隨著醫療保健系統將病人安全、臨床結果、看護者效率和資產管理相結合，治療床市場正進入一個更具戰略意義的階段。人口老化、肥胖症的流行、慢性病負擔的加重以及康復護理的擴展，都推動了對減壓床、肥胖患者支撐床、重症監護體位床、康復支持床和家用治療床解決方案的需求成長。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 治療床市場：依產品類型分類

  • 手動操作的治療床
  • 半電動治療床
  • 全電動治療床

第8章 治療床市場：依技術類型分類

  • 連體床
  • 氣流床和低氣損床
  • 動力治療床

第9章 治療床市場：依治療類型分類

  • 壓力緩解療法
  • 呼吸治療
  • 重症監護治療
  • 復健治療

第10章 治療床市場：依使用環境分類

  • 急性護理
  • 慢性病護理
  • 術後護理

第11章 治療床市場：依最終用戶分類

  • 醫院
  • 診所
  • 家庭醫療保健服務提供者
  • 療養院
  • 門診部

第12章 治療床市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 治療床市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 治療床市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Amico Group of Companies
  • Antano Group Srl
  • Arjo AB
  • Baxter International Inc.
  • Besco Medical Limited
  • Drive DeVilbiss Healthcare
  • Gendron, Inc.
  • Getinge AB
  • GF Health Products, Inc.
  • Hard Manufacturing Company, Inc.
  • Hebei Pukang Medical Instruments Co., Ltd.
  • Invacare Corporation
  • Joerns Healthcare LLC
  • LINET Group SE
  • Malvestio SpA
  • Medline Industries, LP
  • NOA Medical Industries, Inc.
  • Paramount Bed Holdings Co., Ltd.
  • PROMA REHA, sro
  • Savion Industries
  • Span-America Medical Systems, Inc.
  • Stiegelmeyer GmbH & Co. KG
  • Stryker Corporation
  • Transfer Master Products, Inc.
  • Zhangjiagang Medi Medical Equipment Co., Ltd.
Product Code: MRR-030298DFF749

The Therapeutic Bed Market is projected to grow by USD 6.90 billion at a CAGR of 5.29% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.81 billion
Estimated Year [2026] USD 5.05 billion
Forecast Year [2032] USD 6.90 billion
CAGR (%) 5.29%

Therapeutic Bed Market Introduction

The therapeutic bed market is expanding as healthcare providers, long-term care operators, home healthcare agencies, and rehabilitation centers prioritize pressure injury prevention, patient mobility, infection control, and operational efficiency. Therapeutic beds include low-air-loss beds, air-fluidized beds, alternating-pressure mattresses, bariatric beds, critical care beds, and smart hospital beds designed to redistribute pressure, improve positioning, support wound care, and reduce caregiver burden.

Demand is underpinned by verifiable demographic and clinical drivers. The United Nations projects that people aged 65 and older will account for about one in six people globally by 2050, while the World Health Organization reported that more than 1 billion people were living with obesity in 2022. These trends increase the prevalence of immobility, chronic wounds, musculoskeletal disorders, and high-acuity care needs, making therapeutic support surfaces a strategic procurement category across hospitals and post-acute care settings.

For executives, the market opportunity is moving beyond basic bed replacement cycles. Buyers increasingly assess total cost of care, pressure injury reduction, interoperability with nurse call systems and electronic health records, ease of cleaning, energy efficiency, service uptime, and reimbursement alignment. Companies that combine clinical evidence, connected-bed functionality, and reliable after-sales support are best positioned to compete in a more outcomes-focused therapeutic bed industry.

Transformative Shifts in the Therapeutic Bed Landscape

The therapeutic bed landscape is being reshaped by the shift from reactive patient support to proactive, data-enabled care. Hospitals are standardizing pressure redistribution surfaces and advanced positioning systems to reduce hospital-acquired pressure injuries, a complication that the Agency for Healthcare Research and Quality has associated with significant morbidity, longer stays, and billions of dollars in annual U.S. treatment costs. This has elevated therapeutic beds from capital equipment to a measurable quality-of-care investment.

Post-acute and home care are also transforming demand. Shorter hospital stays, aging populations, and preference for care at home are increasing the use of medical beds in skilled nursing facilities, rehabilitation centers, hospice, and residential settings. At the same time, bariatric care requirements are pushing manufacturers to design higher weight-capacity frames, wider sleep decks, stronger motors, safer transfer systems, and more durable pressure management surfaces.

Supply-side competition is shifting toward modularity and connected platforms. Procurement teams increasingly favor beds that can be upgraded with sensors, patient exit alarms, integrated scales, bed-exit monitoring, pulmonary therapy functions, and digital maintenance diagnostics. Manufacturers that reduce lifecycle cost while improving clinical usability are gaining an advantage over suppliers competing mainly on unit price.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating a cumulative impact across therapeutic bed design, utilization, and service delivery. AI-enabled beds can support continuous monitoring of patient movement, bed-exit risk, moisture, weight change, and positioning patterns. When integrated with clinical workflows, these capabilities help caregivers prioritize turning schedules, identify fall risks, and intervene earlier for patients at risk of pressure injuries or respiratory complications.

AI is also improving asset utilization. Predictive maintenance algorithms can analyze motor performance, sensor behavior, and service histories to anticipate component failure and reduce bed downtime. For hospitals managing large fleets, better uptime and location visibility can reduce rental dependence, improve throughput, and support more accurate capital planning.

The most valuable AI applications will be those that are clinically validated, explainable, and privacy-conscious. Buyers will expect compliance with health data regulations, secure connectivity, cybersecurity controls, and transparent evidence that AI-driven alerts reduce alarm fatigue rather than add workflow burden. Vendors that pair AI with human-centered design and rigorous clinical validation will define the next generation of smart therapeutic beds.

Key Regional Insights Across Global Therapeutic Bed Markets

In Asia-Pacific, therapeutic bed demand is supported by hospital infrastructure expansion, aging populations in Japan, China, and South Korea, and rising chronic disease prevalence across India and Southeast Asia. Public and private hospital investments are creating opportunities for smart hospital beds, ICU beds, and cost-effective pressure relief surfaces tailored to high-volume care environments.

North America remains a high-value region due to advanced hospital networks, strong adoption of pressure injury prevention protocols, and established post-acute care infrastructure. The United States leads regional demand through hospital modernization, skilled nursing needs, bariatric care, and home healthcare growth, while Canada's publicly funded healthcare system supports procurement tied to safety, durability, and evidence-based outcomes.

Latin America is advancing as Brazil and Mexico expand hospital capacity, private healthcare access, and rehabilitation services, although procurement budgets vary widely by payer mix and public-sector funding cycles. Europe emphasizes quality standards, sustainability, and patient safety, with the European Union influencing procurement through medical device regulation, environmental objectives, and cross-border care expectations. In the Middle East, GCC hospital investments, specialty care expansion, and medical tourism initiatives support premium therapeutic bed adoption, while Africa presents long-term potential as healthcare infrastructure, critical care capacity, and international health funding continue to develop.

Key Group Insights for Therapeutic Bed Demand

ASEAN countries are gaining importance as hospital construction, urbanization, and rising healthcare expenditure increase demand for affordable therapeutic beds and pressure management surfaces. Procurement in this group often balances cost sensitivity with the need for durable, easy-to-maintain products suited to high patient volumes and varied infrastructure readiness.

The GCC represents a premium opportunity, driven by modernization of tertiary hospitals, specialty care centers, and medical tourism strategies. Buyers across the Gulf typically value advanced ICU beds, connected functionality, bariatric capability, infection-control design, and strong service coverage.

The European Union is shaped by strict medical device compliance, patient safety requirements, sustainability expectations, and harmonized regulatory oversight. BRICS markets offer scale, with China and India driving broad adoption, Brazil contributing regional demand in Latin America, Russia emphasizing localized procurement and health-system investment, and South Africa supporting African healthcare access. G7 markets lead in evidence-based procurement, smart therapeutic bed adoption, and lifecycle service models, while NATO countries emphasize resilient healthcare infrastructure, emergency preparedness, and interoperable medical assets for both civilian and contingency care settings.

Key Country Insights in the Therapeutic Bed Market

The United States is the most influential country market for therapeutic beds due to high healthcare spending, large hospital networks, skilled nursing demand, bariatric care requirements, and a strong focus on pressure injury prevention. Canada favors clinically proven and durable systems aligned with public healthcare procurement and provincial care standards, while Mexico is benefiting from private hospital expansion, cross-border medical care, and modernization of acute care facilities.

Brazil leads Latin American demand through its large healthcare system, expanding private hospital sector, and rehabilitation needs. In Europe, the United Kingdom prioritizes health-system capacity, patient safety, and long-term care needs; Germany benefits from advanced hospital infrastructure and engineering-led procurement; France focuses on quality care, reimbursement alignment, and aging-related care demand; Russia's market is influenced by domestic healthcare investment and procurement localization; Italy and Spain support demand through aging populations, rehabilitation services, and pressure injury prevention programs.

China is scaling hospital infrastructure and elderly care capacity, creating demand across value and premium segments. India is advancing through private hospitals, medical tourism, expanding critical care capacity, and growing chronic disease management needs. Japan has strong demand linked to one of the world's oldest populations and long-term care requirements, Australia supports adoption through high care standards, rehabilitation demand, and home healthcare services, and South Korea emphasizes technologically advanced hospital systems, digital health integration, and high-acuity care modernization.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated therapeutic beds that demonstrate measurable reductions in pressure injury risk, caregiver strain, fall events, and downtime. Evidence generation is essential: manufacturers should invest in real-world studies, health economic models, and outcome-based case studies that help procurement teams justify premium products through total cost-of-care savings.

Product strategy should focus on modular platforms that allow hospitals to upgrade from basic therapeutic support to connected monitoring, integrated scales, automated turning, bed-exit alerts, and predictive maintenance. Service capability is equally important; rapid repair, preventive maintenance, user training, and rental or leasing options can materially influence purchasing decisions.

Companies should also localize offerings by region. Premium smart beds may fit North America, the GCC, Japan, South Korea, Australia, and Western Europe, while durable, cost-efficient therapeutic surfaces and semi-electric beds may better serve emerging markets. Cybersecurity, regulatory compliance, cleaning efficiency, infection-control design, and sustainability should be treated as core product requirements rather than optional features.

Research Methodology

This executive summary is based on a structured secondary-research approach using publicly available and institutionally recognized sources, including health agencies, demographic databases, hospital quality literature, medical device regulatory frameworks, and healthcare infrastructure indicators. Key reference points include data and guidance from organizations such as the World Health Organization, United Nations, World Bank, Agency for Healthcare Research and Quality, and national healthcare authorities.

The methodology assesses demand drivers across clinical need, demographics, care settings, procurement behavior, technology adoption, and regional infrastructure maturity. Qualitative insights were triangulated across hospital modernization trends, pressure injury prevention priorities, aging and obesity data, post-acute care expansion, home healthcare adoption, and connected medical device integration.

Market conclusions are presented without unsupported revenue figures. Instead, the analysis emphasizes verified macro indicators, regulatory context, clinical burden, and purchasing factors that shape therapeutic bed adoption across hospitals, long-term care, rehabilitation, and home healthcare.

Conclusion

The therapeutic bed market is entering a more strategic phase as healthcare systems connect patient safety, clinical outcomes, caregiver efficiency, and asset management. Aging populations, obesity prevalence, chronic disease burden, and post-acute care growth are expanding the need for pressure redistribution, bariatric support, critical care positioning, rehabilitation support, and home-based therapeutic bed solutions.

Artificial intelligence and connected-bed platforms will increasingly define competitive advantage, but adoption will depend on clinical validation, secure interoperability, cybersecurity readiness, and workflow-friendly design. Regional opportunities will vary by infrastructure maturity and purchasing power, with North America, Europe, the GCC, and advanced Asia-Pacific markets leading premium adoption while emerging economies drive scalable demand.

Companies that align innovation with evidence, affordability, service reliability, regulatory compliance, and localized product design will be best positioned to capture growth in the global therapeutic bed industry.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Therapeutic Bed Market, by Product Type

  • 7.1. Manual Therapeutic Beds
  • 7.2. Semi-Electric Therapeutic Beds
  • 7.3. Fully Electric Therapeutic Beds

8. Therapeutic Bed Market, by Technology Type

  • 8.1. Connected Beds
  • 8.2. Air Fluidized & Low Air Loss Beds
  • 8.3. Kinetic Therapy Beds

9. Therapeutic Bed Market, by Therapy Type

  • 9.1. Pressure Relief Therapy
  • 9.2. Pulmonary Therapy
  • 9.3. Critical Care Therapy
  • 9.4. Rehabilitation Therapy

10. Therapeutic Bed Market, by Usage Setting

  • 10.1. Acute Care
  • 10.2. Chronic Care
  • 10.3. Post-Surgical Care

11. Therapeutic Bed Market, by End User

  • 11.1. Hospitals
  • 11.2. Clinics
  • 11.3. Home Healthcare Providers
  • 11.4. Nursing Homes
  • 11.5. Ambulatory Care Centers

12. Therapeutic Bed Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Therapeutic Bed Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Therapeutic Bed Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Amico Group of Companies
  • 16.2. Antano Group S.r.l.
  • 16.3. Arjo AB
  • 16.4. Baxter International Inc.
  • 16.5. Besco Medical Limited
  • 16.6. Drive DeVilbiss Healthcare
  • 16.7. Gendron, Inc.
  • 16.8. Getinge AB
  • 16.9. GF Health Products, Inc.
  • 16.10. Hard Manufacturing Company, Inc.
  • 16.11. Hebei Pukang Medical Instruments Co., Ltd.
  • 16.12. Invacare Corporation
  • 16.13. Joerns Healthcare LLC
  • 16.14. LINET Group SE
  • 16.15. Malvestio S.p.A.
  • 16.16. Medline Industries, LP
  • 16.17. NOA Medical Industries, Inc.
  • 16.18. Paramount Bed Holdings Co., Ltd.
  • 16.19. PROMA REHA, s.r.o.
  • 16.20. Savion Industries
  • 16.21. Span-America Medical Systems, Inc.
  • 16.22. Stiegelmeyer GmbH & Co. KG
  • 16.23. Stryker Corporation
  • 16.24. Transfer Master Products, Inc.
  • 16.25. Zhangjiagang Medi Medical Equipment Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL THERAPEUTIC BED MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL THERAPEUTIC BED MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL THERAPEUTIC BED MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL THERAPEUTIC BED MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL THERAPEUTIC BED MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL THERAPEUTIC BED MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL THERAPEUTIC BED MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL THERAPEUTIC BED MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL THERAPEUTIC BED MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL THERAPEUTIC BED MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL THERAPEUTIC BED MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL THERAPEUTIC BED MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL THERAPEUTIC BED MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL THERAPEUTIC BED MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MANUAL THERAPEUTIC BEDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MANUAL THERAPEUTIC BEDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MANUAL THERAPEUTIC BEDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SEMI-ELECTRIC THERAPEUTIC BEDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SEMI-ELECTRIC THERAPEUTIC BEDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SEMI-ELECTRIC THERAPEUTIC BEDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FULLY ELECTRIC THERAPEUTIC BEDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FULLY ELECTRIC THERAPEUTIC BEDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FULLY ELECTRIC THERAPEUTIC BEDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONNECTED BEDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONNECTED BEDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONNECTED BEDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AIR FLUIDIZED & LOW AIR LOSS BEDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AIR FLUIDIZED & LOW AIR LOSS BEDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AIR FLUIDIZED & LOW AIR LOSS BEDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL KINETIC THERAPY BEDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL KINETIC THERAPY BEDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL KINETIC THERAPY BEDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PRESSURE RELIEF THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PRESSURE RELIEF THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PRESSURE RELIEF THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PULMONARY THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PULMONARY THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PULMONARY THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CRITICAL CARE THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CRITICAL CARE THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CRITICAL CARE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL REHABILITATION THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL REHABILITATION THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL REHABILITATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ACUTE CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ACUTE CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ACUTE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CHRONIC CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CHRONIC CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CHRONIC CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POST-SURGICAL CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POST-SURGICAL CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POST-SURGICAL CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NURSING HOMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NURSING HOMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NURSING HOMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL THERAPEUTIC BED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL THERAPEUTIC BED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. GCC THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 106. GCC THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. GCC THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. GCC THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. GCC THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 110. GCC THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. G7 THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. G7 THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. G7 THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. G7 THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. G7 THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 128. G7 THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. NATO THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. NATO THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. NATO THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NATO THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. NATO THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 134. NATO THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL THERAPEUTIC BED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. CANADA THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. CANADA THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. CANADA THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. CANADA THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. CANADA THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 147. CANADA THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. MEXICO THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. MEXICO THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. MEXICO THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MEXICO THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. MEXICO THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 153. MEXICO THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. BRAZIL THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. BRAZIL THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. BRAZIL THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. BRAZIL THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRAZIL THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 159. BRAZIL THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED KINGDOM THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED KINGDOM THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED KINGDOM THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED KINGDOM THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED KINGDOM THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED KINGDOM THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. GERMANY THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. GERMANY THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. GERMANY THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GERMANY THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. GERMANY THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 171. GERMANY THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. FRANCE THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. FRANCE THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. FRANCE THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. FRANCE THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. FRANCE THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 177. FRANCE THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. RUSSIA THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. RUSSIA THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. RUSSIA THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. RUSSIA THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. RUSSIA THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 183. RUSSIA THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. ITALY THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. ITALY THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ITALY THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ITALY THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ITALY THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 189. ITALY THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. SPAIN THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. SPAIN THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. SPAIN THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. SPAIN THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. SPAIN THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 195. SPAIN THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. INDIA THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. INDIA THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. INDIA THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. INDIA THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. INDIA THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 207. INDIA THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. JAPAN THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. JAPAN THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. JAPAN THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. JAPAN THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. JAPAN THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 213. JAPAN THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. AUSTRALIA THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. AUSTRALIA THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. AUSTRALIA THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. AUSTRALIA THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. AUSTRALIA THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 219. AUSTRALIA THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. SOUTH KOREA THERAPEUTIC BED MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. SOUTH KOREA THERAPEUTIC BED MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. SOUTH KOREA THERAPEUTIC BED MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. SOUTH KOREA THERAPEUTIC BED MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. SOUTH KOREA THERAPEUTIC BED MARKET SIZE, BY USAGE SETTING, 2018-2032 (USD MILLION)
  • TABLE 225. SOUTH KOREA THERAPEUTIC BED MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)